Selleck Chemicals - Model A2669 -Lusvertikimab (Anti-IL-7Ra / CD127)

Lusvertikimab (Anti-IL-7Ra / CD127) is a humanized monoclonal antibody targeting IL7R. It has anti-leukemic efficacy and has the potential for B cell precursor acute lymphoblastic leukemia (BCP-ALL) research. MW :145.64 KD.